ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Dakota » Ophthalmology

Top Ophthalmology Prescribers in North Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MONTE LEIDENIX M.D. F.A.C.S.

Ophthalmology

4,821

$199K

917
864 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

22%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

43%
prescriptions for brand name drugs

Avg: 58%

$41
Average prescription price

Avg: $56

DOUGLAS LITCHFIELD MD

Ophthalmology

3,638

$181K

733
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

54%
prescriptions for brand name drugs

Avg: 58%

$50
Average prescription price

Avg: $56

RONALD BROCKMAN MD

Ophthalmology

3,111

$209K

789
744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

76%
prescriptions for brand name drugs

Avg: 58%

$67
Average prescription price

Avg: $56

MARK SCZEPANSKI M.D.

Ophthalmology

3,050

$226K

586
561 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

78%
prescriptions for brand name drugs

Avg: 58%

$74
Average prescription price

Avg: $56

HAROLD RODENBIKER M.D.

Ophthalmology

2,919

$134K

558
529 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

21%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

58%
prescriptions for brand name drugs

Avg: 58%

$46
Average prescription price

Avg: $56

STEVEN ANDERSON M.D.

Ophthalmology

2,623

$186K

492
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

73%
prescriptions for brand name drugs

Avg: 58%

$71
Average prescription price

Avg: $56

AARON FORTNEY MD

Ophthalmology

2,618

$144K

518
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

65%
prescriptions for brand name drugs

Avg: 58%

$55
Average prescription price

Avg: $56

GEORGE HILTS MD

Ophthalmology

2,615

$174K

490
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

66%
prescriptions for brand name drugs

Avg: 58%

$67
Average prescription price

Avg: $56

RAYMOND LARSEN M.D.

Ophthalmology

2,490

$204K

489
463 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

71%
prescriptions for brand name drugs

Avg: 58%

$82
Average prescription price

Avg: $56

ANDREW JORDAN MD

Ophthalmology

2,394

$108K

525
470 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

48%
prescriptions for brand name drugs

Avg: 58%

$45
Average prescription price

Avg: $56

MARK RAYMOND MD

Ophthalmology

2,344

$136K

472
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

55%
prescriptions for brand name drugs

Avg: 58%

$58
Average prescription price

Avg: $56

STEVEN BAGAN M.D.

Ophthalmology

2,155

$93.4K

332
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

54%
prescriptions for brand name drugs

Avg: 58%

$43
Average prescription price

Avg: $56

CHARLES VOLK MD

Ophthalmology

2,136

$121K

534
511 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

65%
prescriptions for brand name drugs

Avg: 58%

$57
Average prescription price

Avg: $56

ANNE KEATING M.D.

Ophthalmology

1,966

$125K

389
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

57%
prescriptions for brand name drugs

Avg: 58%

$64
Average prescription price

Avg: $56

CHAD WOLSKY MD

Ophthalmology

1,942

$109K

444
408 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

63%
prescriptions for brand name drugs

Avg: 58%

$56
Average prescription price

Avg: $56

THOMAS STRINDEN MD

Ophthalmology

1,941

$151K

465
444 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

75%
prescriptions for brand name drugs

Avg: 58%

$78
Average prescription price

Avg: $56

JULIANA REEVES MD

Ophthalmology

1,831

$98.3K

316
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

54%
prescriptions for brand name drugs

Avg: 58%

$54
Average prescription price

Avg: $56

DARRELL WILLIAMS MD

Ophthalmology

1,781

$67.7K

481
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

46%
prescriptions for brand name drugs

Avg: 58%

$38
Average prescription price

Avg: $56

DAVID GROSZ M.D.

Ophthalmology

1,768

$84K

281
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

62%
prescriptions for brand name drugs

Avg: 58%

$48
Average prescription price

Avg: $56

GERALD GAUL M.D.

Ophthalmology

1,164

$54.9K

332
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

51%
prescriptions for brand name drugs

Avg: 58%

$47
Average prescription price

Avg: $56

NORMAN BYERS MD

Ophthalmology

1,047

$48.6K

187
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

38%
prescriptions for brand name drugs

Avg: 58%

$46
Average prescription price

Avg: $56

THOMAS GRUBE MD

Ophthalmology

913

$28.7K

274
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

51%
prescriptions for brand name drugs

Avg: 58%

$31
Average prescription price

Avg: $56

EVELYNE BOUCHARD-KINDY MD

Ophthalmology

908

$41.5K

158
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

51%
prescriptions for brand name drugs

Avg: 58%

$46
Average prescription price

Avg: $56

ROBERT DICKEN MD

Ophthalmology

864

$44.7K

156
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

59%
prescriptions for brand name drugs

Avg: 58%

$52
Average prescription price

Avg: $56

ROBERT SANKE MD

Ophthalmology

725

$39.8K

135
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 6%

52%
prescriptions for brand name drugs

Avg: 58%

$55
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank